Skin Awareness SDBM (@SDBehindTheMask) header
Skin Awareness SDBM (@SDBehindTheMask) profile picture

'Not for profit' organisation dedicated to 'Support' 'Inform' and 'Improve' the quality of lives for 'carers of' as well as sufferers of skin disease

London, UK
Joined March 2009
Photo by Skin Awareness SDBM (@SDBehindTheMask)Photo by Skin Awareness SDBM (@SDBehindTheMask)Photo by Skin Awareness SDBM (@SDBehindTheMask)Photo by Skin Awareness SDBM (@SDBehindTheMask)Photo by Skin Awareness SDBM (@SDBehindTheMask)Photo by Skin Awareness SDBM (@SDBehindTheMask)Photo by Skin Awareness SDBM (@SDBehindTheMask)Photo by Skin Awareness SDBM (@SDBehindTheMask)Photo by Skin Awareness SDBM (@SDBehindTheMask)Photo by Skin Awareness SDBM (@SDBehindTheMask)
Is it a pimple or a boil? - Boils and pimples may have similar appearances, but they often have different causes. Learn how to tell boils from pimples and treat outbreaks. ow.ly/nikr50gX2ob
1
1
2
US expands scope of Seattle Genetics’ Adcetris - US regulators have approved Seattle Genetics’ Adcetris in combination with chemotherapy for adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma. ow.ly/XYse50gWWIn
3
NICE rejects rare eye disease drug - Cost regulators for NHS therapies in England and Wales have published draft guidelines rejecting funding for Dompé’s cenegermin as a treatment for neurotrophic keratitis, a rare eye condition. ow.ly/yjfX50gW2kH
1
How to get rid of blood-filled pimples - Blood-filled pimples occur after someone picks, squeezes, or pops a regular pimple. Learn about how to treat and prevent them here. ow.ly/U0jH50gV8WH
1
Performance on A&E target slips further - NHS hospital performance against the four-hour A&E target stood at just 74.96 percent, well under the 95 percent target, for the week ending March 11th, show the most recent data from the Royal College of Emer... ow.ly/wjHh50gV5rS
What are these white spots on my nipples? - Learn about different causes of white spots on the nipples, including those linked with breast-feeding. We also look at other symptoms and treatments. ow.ly/zKaV50gTEeQ
1
Is it safe to use baking soda on hair? - Increasingly, people are using baking soda to clean their hair. However, this is not always safe. Learn about risks and other natural hair remedies here. ow.ly/sDbV50gT1lu
1
PharmaTimes Clinical Researcher of the Year – The Americas: Book now! - Clinical researchers in the Americas have submitted their essays for this year's competition and yesterday, the authors and finalists were revealed at a meeting of the executive s... ow.ly/dM5R50gSXyl
Can you have internal shingles without a rash? - Shingles usually causes a painful, blistering rash. It can also cause internal symptoms, appear without a rash, and may spread to internal organs. ow.ly/DEf550gS7uX
Researchers call for investigation into rising mortality rates - Researchers are calling for a government investigation into the “substantial increase” in mortality seen in early 2018 in England and Wales. ow.ly/9RY550gS2Ga
Chancellor criticised for lack of action on NHS - Chancellor Philip Hammond boosted growth projections and forecast falling inflation for the UK in his Spring Statement, but health care leaders lamented his lack of action on addressing the NHS crisis. ow.ly/49wN50gR8nu
Researchers discover ‘new line of attack’ on triple negative breast cancer - Scientists have uncovered a novel approach to fighting hard-to-treat breast cancers, triggering a new drug programme designed to develop novel targeted therapies for the dise... ow.ly/ugEL50gQf6P
Hikma/Vectura’s generic Advair delayed in the US - US regulators have upheld a prior decision rejecting Hikma and Vectura’s generic formulation of GlaxoSmithKline's asthma and chronic obstructive pulmonary syndrome therapy Advair Diskus. ow.ly/EgKz50gPi8r
EU expands scope of GSK/Innoviva’s asthma inhaler - The European Commission has approved a label update to GlaxoSmithKline/Innoviva’s Relvar Ellipta, expanding the asthma therapy’s reach. ow.ly/F00C50gNfsD
Finalists announced! - Following a meeting of the executive steering group, PharmaTimes Media is delighted to reveal the 2018 International Clinical Researcher of the Year finalists... ow.ly/9i2Q50gMlIQ
BI, Lilly expand Jardiance programme in heart failure - Boehringer Ingelheim and Eli Lilly are expanding their clinical trial programme for Jardiance in chronic heart failure (CHF) with two new Phase III studies. ow.ly/71Et50gLrT0